Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

As part of its ongoing RAK Diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the ...

As part of its ongoing RAK diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the LINK between diabetes and kidney disease, shedding light on the prevention ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and chronic kidney disease.

Off-label SGLT2 inhibitors increase the risk of euglycemic diabetic ketoacidosis. GLP-1RAs may lead to rapid weight loss in ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- Semaglutide (Wegovy) reduced ...